Investment
CNBC
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Why This Matters
Patients can pay $499 in cash per month for three dose sizes of Ozempic through the company's direct-to-consumer pharmacy and GoodRx, among other platforms.
August 18, 2025
03:19 PM
3 min read
Stay Ahead of the Market
Get weekly insights into market shifts, investment opportunities, and financial analysis delivered to your inbox.
No spam, unsubscribe anytime